Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol target-controlled infusion vs manual injection in painless transvaginal oocyte retrieval
ChiCTR2300074891Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol in procedural pain (2 arms), sponsored by Guangdong Provincial Hospital of Chinese Medicine. Primary endpoint: Total propofol dosage. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
procedural pain
Beyond the preview
Go deeper on ChiCTR2300074891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074891.